Pharmacokinetics linearity [Regulatives / Guidelines]

posted by pjs – India, 2015-05-28 18:11 (3633 d 13:23 ago) – Posting: # 14875
Views: 4,536

Dear nobody,

Apologies for the wrong terminology. What i mean to say was extrapolating the linearity on lower range. I also had doubts regarding this option as mentioned in my earlier post. But just wanted to know forum members view on that.

Apart from point 3 of earlier post would like to know view about the 1st and 2nd point of the forum members.

Has any body experinece in filling generic product in which similar extrapolation of the linearity has been done and accepted by the agency.

Thanks.

Regards,
PJS

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,671 registered users;
147 visitors (0 registered, 147 guests [including 3 identified bots]).
Forum time: 07:35 CEST (Europe/Vienna)

Freedom is always and exclusively
freedom for the one
who thinks differently.    Rosa Luxemburg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5